JPMORGAN CHASE & CO - F-STAR THERAPEUTICS INC ownership

F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 1 filers reported holding F-STAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of F-STAR THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$0
-100.0%
78
-94.8%
0.00%
Q2 2022$9,000
-88.2%
1,498
-93.0%
0.00%
Q1 2022$76,000
+81.0%
21,335
+152.7%
0.00%
Q4 2021$42,0008,4440.00%
Other shareholders
F-STAR THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 574,996$2,944,0001.06%
AlphaCentric Advisors LLC 165,000$845,0000.87%
DAFNA Capital Management LLC 576,881$2,954,0000.80%
Knott David M Jr 235,945$1,208,0000.51%
Atlas Venture Life Science Advisors, LLC 599,524$3,070,0000.34%
S. MUOIO & CO. LLC 40,000$205,0000.27%
Murchinson Ltd. 162,624$833,0000.24%
Connolly Sarah T. 53,001$271,0000.20%
BCK CAPITAL MANAGEMENT LP 52,000$266,0000.19%
Diametric Capital, LP 44,449$228,0000.12%
View complete list of F-STAR THERAPEUTICS INC shareholders